Endo International Ordinary Shares reported $179.76M in Cost of Sales for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Cost Of Sales Change
Abbvie ABBV:US $ 4142M 121M
Aerie Pharmaceuticals AERI:US $ 3.74M 3.04M
Amarin AMRN:US $ 35.81M 13.57M
Ani Pharmaceuticals ANIP:US $ 35.29M 1.02M
Bristol Myers Squibb BMY:US $ 2677M 206M
Coherus Biosciences CHRS:US $ 11.28M 1.91M
Eli Lilly And LLY:US $ 1430.5M 641.6M
Endo International Ordinary Shares ENDP:US $ 179.76M 42.71M
Heron Therapeutics HRTX:US $ 11.36M 0.41M
Hikma Pharmaceutical HIK:LN 590M 62M
Horizon Pharma HZNP:US $ 230.22M 15.15M
JAZZ PHA JAZZ:US $ 124.21M 8.92M
Lannett LCI:US $ 75.28M 5.52M
Ligand Pharmaceuticals LGND:US $ 12.36M 7.66M
Merk MRK:US $ 3698M 1636M
Novartis NOVN:VX SF 3749M 6M
Pacira Pharmaceuticals PCRX:US $ 50.63M 14.55M
Perrigo Ordinary Shares PRGO:US $ 736.7M 5.8M
Pfizer PFE:US $ 8671M 1339M
Phibro Animal Health PAHC:US $ 167.99M 5.95M
Revance Therapeutics RVNC:US $ 7.89M 12K
Supernus Pharmaceuticals SUPN:US $ 20.46M 2.52M
Takeda 4502:JP Y 292882M 15498M
Teva Pharmaceutical TEVA:IT 1.96B 99M
Xeris Pharmaceuticals Inc XERS:US $ 6.27M 1.38M
Zoetis ZTS:US $ 620M 55M